Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Thomassen, Mads ^a   Tan, Qihua ^b   Kruse, Torben A ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; NUCLEAR FACTOR Y; PLATELET DERIVED GROWTH FACTOR; PROTEASOME; SEX HORMONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR YY1; VASCULOTROPIN; DNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL CYCLE REGULATION; CELL MIGRATION; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC DATABASE; GLUCOSE METABOLISM; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; METABOLIC REGULATION; METASTASIS; SIGNAL TRANSDUCTION; UPREGULATION; BREAST TUMOR; CANCER INVASION; FEMALE; GENE EXPRESSION; GENETICS; META ANALYSIS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

BREAST NEOPLASMS; DNA REPAIR; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 60949083872     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-394     Document Type: Article

References (44)

1. Thomassen M Tan Q Eiriksdottir F Bak M Cold S Kruse TA Prediction of metastasis from low-malignant breast cancer by gene expression profiling Int J Cancer 2007, 120:1070-1075. 10.1002/ijc.22449 17131339
2. Huang E Cheng SH Dressman H Pittman J Tsou MH Horng CF Bild A Iversen ES Liao M Chen CM West M Nevins JR Huang AT Gene expression predictors of breast cancer outcomes Lancet 2003, 361:1590-1596. 10.1016/ S0140-6736(03)13308-9 12747878
3. Sotiriou C Neo SY McShane LM Korn EL Long PM Jazaeri A Martiat P Fox SB Harris AL Liu ET Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 2003, 100:10393-10398. 193572 12917485 10.1073/pnas.1732912100
4. Sotiriou C Wirapati P Loi S Harris A Fox S Smeds J Nordgren H Farmer P Praz V Haibe-Kains B Desmedt C Larsimont D Cardoso F Peterse H Nuyten D Buyse M van de Vijver MJ Bergh J Piccart M Delorenzi M Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 2006, 98:262-272. 16478745
5. Wang Y Klijn JG Zhang Y Sieuwerts AM Look MP Yang F Talantov D Timmermans M Meijer-van Gelder ME Yu J Jatkoe T Berns EM Atkins D Foekens JA Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 2005, 365:671-679. 15721472
6. van de Vijver MJ He YD van't Veer LJ Dai H Hart AA Voskuil DW Schreiber GJ Peterse JL Roberts C Marton MJ Parrish M Atsma D Witteveen A Glas A Delahaye L van der Velde T Bartelink H Rodenhuis S Rutgers ET Friend SH Bernards R A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 2002, 347:1999-2009. 10.1056/NEJMoa021967 12490681
7. Miller LD Smeds J George J Vega VB Vergara L Ploner A Pawitan Y Hall P Klaar S Liu ET Bergh J An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 2005, 102:13550-13555. 1197273 16141321 10.1073/pnas.0506230102
8. Calza S Hall P Auer G Bjohle J Klaar S Kronenwett U Liu ET Miller L Ploner A Smeds J Bergh J Pawitan Y Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients Breast Cancer Res 2006, 8:R34. 1779468 16846532 10.1186/bcr1517
9. Tan Q Thomassen M Kruse TA Feature Selection for Predicting Tumor Metastases in Microarray Experiments using Paired Design Cancer Informatics 2007, 2:133-138.
10. van 't Veer LJ Dai H Vijver van de MJ He YD Hart AAM Mao M Peterse HL Kooy van der K Marton MJ Witteveen AT Schreiber GJ Kerkhoven RM Roberts C Linsley PS Bernards R Friend SH Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415(6871):530-536. 10.1038/415530a 11823860
11. Pawitan Y Bjohle J Amler L Borg AL Egyhazi S Hall P Han X Holmberg L Huang F Klaar S Liu ET Miller L Nordgren H Ploner A Sandelin K Shaw PM Smeds J Skoog L Wedren S Bergh J Gene expression profiling spares early breast cancer patients from adjuvant therapy: Derived and validated in two population-based cohorts Breast Cancer Res 2005, 7:R953-R964. 1410752 16280042 10.1186/bcr1325
12. Thomassen M Tan Q Eiriksdottir F Bak M Cold S Kruse TA Comparison of gene sets for expression profiling: Prediction of metastasis from low-malignant breast cancer Clin Cancer Res 2007, 13:5355-5360. 10.1158/ 1078-0432.CCR-07-0249 17875763
13. Xie X Lu J Kulbokas EJ Golub TR Mootha V Lindblad-Toh K Lander ES Kellis M Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals Nature 2005, 434:338-345. 10.1038/nature03441 15735639
14. Bild AH Yao G Chang JT Wang Q Potti A Chasse D Joshi MB Harpole D Lancaster JM Berchuck A Olson JA Jr Marks JR Dressman HK West M Nevins JR Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature 2006, 439:353-357. 10.1038/nature04296 16273092
15. Subramanian A Tamayo P Mootha VK Mukherjee S Ebert BL Gillette MA Paulovich A Pomeroy SL Golub TR Lander ES Mesirov JP Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci USA 2005, 102:15545-15550. 1239896 16199517 10.1073/pnas.0506580102
16. Tsantoulis PK Gorgoulis VG Involvement of E2F transcription factor family in cancer Eur J Cancer 2005, 41:2403-2414. 10.1016/ j.ejca.2005.08.005 16213134
17. Rakha EA Pinder SE Paish EC Robertson JF Ellis IO Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis J Pathol 2004, 203:754-761. 10.1002/path.1573 15221934
18. Cam H Balciunaite E Blais A Spektor A Scarpulla RC Young R Kluger Y Dynlacht BD A common set of gene regulatory networks links metabolism and growth inhibition Mol Cell 2004, 16:399-411. 10.1016/ j.molcel.2004.09.037 15525513
19. Gordon S Akopyan G Garban H Bonavida B Transcription factor YY1: structure, function, and therapeutic implications in cancer biology Oncogene 2006, 25:1125-1142. 10.1038/sj.onc.1209080 16314846
20. Lo HW Hsu SC Hung MC EGFR signaling pathway in breast cancers: From traditional signal transduction to direct nuclear translocalization Breast Cancer Res Treat 2006, 95:211-218. 10.1007/s10549-005-9011-0 16261406
21. Chan SK Hill ME Gullick WJ The role of the epidermal growth factor receptor in breast cancer J Mammary Gland Biol Neoplasia 2006, 11:3-11. 10.1007/s10911-006-9008-2 16947082
22. Jechlinger M Sommer A Moriggl R Seither P Kraut N Capodiecci P Donovan M Cordon-Cardo C Beug H Grunert S Autocrine PDGFR signaling promotes mammary cancer metastasis J Clin Invest 2006, 116:1561-1570. 1469776 16741576 10.1172/JCI24652
23. Foufelle F Girard J Ferre P Regulation of lipogenic enzyme expression by glucose in liver and adipose tissue: A review of the potential cellular and molecular mechanisms Adv Enzyme Regul 1996, 36:199-226. 10.1016/ 0065-2571(95)00010-0 8869748
24. Bustamante E Morris HP Pedersen PL Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding J Biol Chem 1981, 256:8699-8704. 7263678
25. Lee MG Pedersen PL Glucose metabolism in cancer: Importance of transcription factor-DNA interactions within a short segment of the proximal region og the type II hexokinase promoter J Biol Chem 2003, 278:41047-41058. 10.1074/jbc.M307031200 12893819
26. Isasi CR Moadel RM Blaufox MD A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases Breast Cancer Res Treat 2005, 90:105-112. 10.1007/s10549-004-3291-7 15803356
27. Airley RE Mobasheri A Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics Chemotherapy 2007, 53:233-256. 10.1159/000104457 17595539
28. Bachelder RE Crago A Chung J Wendt MA Shaw LM Robinson G Mercurio AM Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells Cancer Res 2001, 61:5736-5740. 11479209
29. Sledge GW Jr VEGF-targeting therapy for breast cancer J Mammary Gland Biol Neoplasia 2005, 10:319-323. 10.1007/s10911-006-9005-5 16924373
30. Xin X Yang S Kowalski J Gerritsen ME Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo J Biol Chem 1999, 274:9116-9121. 10.1074/jbc.274.13.9116 10085162
31. Jiang WG Douglas-Jones A Mansel RE Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes Int J Cancer 2003, 106:752-757. 10.1002/ijc.11302 12866036
32. Liu H Zang C Fenner MH Possinger K Elstner E PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro Breast Cancer Res Treat 2003, 79:63-74. 10.1023/A:1023366117157 12779083
33. Steeghs N Nortier JW Gelderblom H Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: An update of recent developments Ann Surg Oncol 2007, 14:942-953. 10.1245/s10434-006-9227-1 17103252
34. Kedrin D van RJ Hernandez L Condeelis J Segall JE Cell Motility and Cytoskeletal Regulation in Invasion and Metastasis J Mammary Gland Biol Neoplasia; 2007. 17557195
35. Sarkar S Maceyka M Hait NC Paugh SW Sankala H Milstien S Spiegel S Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells FEBS Lett 2005, 579:5313-5317. 10.1016/j.febslet.2005.08.055 16194537
36. Cardoso F Ross JS Picart MJ Sotiriou C Durbecq V Targeting the ubiquitin-proteasome pathway in breast cancer Clin Breast Cancer 2004, 5:148-157. 10.3816/CBC.2004.n.020 15245620
37. Krieg AM Development of TLR9 agonists for cancer therapy J Clin Invest 2007, 117:1184-1194. 1857270 17476348 10.1172/JCI31414
38. Garay RP Viens P Bauer J Normier G Bardou M Jeannin JF Chiavaroli C Cancer relapse under chemotherapy: Why TLR2/4 receptor agonists can help Eur J Pharmacol 2007, 563:1-17. 10.1016/j.ejphar.2007.02.018 17383632
39. Yoshida K Miki Y Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage Cancer Sci 2004, 95:866-871. 10.1111/j.1349-7006.2004.tb02195.x 15546503
40. Cantor SB Bell DW Ganesan S Kass EM Drapkin R Grossman S Wahrer DC Sgroi DC Lane WS Haber DA Livingston DM BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function Cell 2001, 105:149-160. 10.1016/S0092-8674(01)00304-X 11301010
41. Al-Kuraya K Schraml P Torhorst J Tapia C Zaharieva B Novotny H Spichtin H Maurer R Mirlacher M Kochli O Zuber M Dieterich H Mross F Wilber K Simon R Sauter G Prognostic relevance of gene amplifications and coamplifications in breast cancer Cancer Res 2004, 64:8534-8540. 10.1158/ 0008-5472.CAN-04-1945 15574759
42. Ein-Dor L Kela I Getz G Givol D Domany E Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics 2005, 21:171-178. 10.1093/bioinformatics/bth469 15308542
43. Yu JX Sieuwerts AM Zhang Y Martens JW Smid M Klijn JG Wang Y Foekens JA Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer BMC Cancer 2007, 7:182. 2077336 17894856 10.1186/1471-2407-7-182
44. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB Rijn van de M Jeffrey SS Thorsen T Quist H Matese JC Brown PO Botstein D Eystein Lonning P Borresen Dale AL Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98:10869-74. 2001 Sep 11 58566 11553815 10.1073/pnas.191367098